Objectives-To characterise the cellular interactions and the mechanisms involved in the recruitment ofinflammatory macrophages and T cells to the bone implant interface in 30 patients with aseptically loosened orthopaedic prostheses. Methods-Cell adhesion molecules E-selectin, VCAM-1, ICAM-1 and the receptors LFA-1 and CR3 were immunolocalised on cryostat sections of the bone-implant interface obtained during revision arthroplasty. The percentage of expression on vascular endothelium was determined on serial sections.
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Objectives-To characterise the cellular interactions and the mechanisms involved in the recruitment ofinflammatory macrophages and T cells to the bone implant interface in 30 patients with aseptically loosened orthopaedic prostheses. Methods-Cell adhesion molecules E-selectin, VCAM-1, ICAM-1 and the receptors LFA-1 and CR3 were immunolocalised on cryostat sections of the bone-implant interface obtained during revision arthroplasty. The percentage of expression on vascular endothelium was determined on serial sections.
Results-E-selectin was upregulated on different vessels in 21 patients. Its expression correlated strongly with the presence of metal wear debris. VCAM-1 was detected on vessels in six patients only, and was coexpressed with E-selectin in three patients with metal debris. VCAM-1 was more frequently observed in the lining cells on the implant side. ICAM-1 was upregulated on vessels on the bone side only in 13 patients, and was more strongly expressed on aggregates of macrophages and multinucleated giant cells on the implant side. These macrophage aggregates coexpressed both ICAM-1 and CR3. Conclusion-Our findings implicate the contribution ofthree different pathways in the recruitment of inflammatory cells to the joint in response to orthopaedic implant wear particles. The association of E-selectin expression and metal debris may suggest hypersensitivity reactions. Finally, the simultaneous expression of ICAM-1 and CR3 on the same macrophages on the implant side may predict an additional function of these molecules in homotypic adhesion/cell aggregation that precede differentiation of phagocytes to multinucleated giant cells.
(Ann Rheum Dis 1995; 54: 201-208) Osteoclastic bone resorption is a well documented phenomenon in association with aseptic loosening of total joint replacements. Considerable attention has focused on this problem following various reports of osteolysis and bone necrosis around stable and well fixed implants that show no sign of loosening.' 2 Various studies demonstrated that bone loss adjacent to orthopaedic implants is linked to a local inflammatory cellular response at the bone-implant interface. 3 Histological assessment of the interface membranes by our group and others indicates that these tissues develop initially in a form of fibrous stroma with a small number of macrophages and few or no vessels present. 4 In comparison, membranes retrieved during revision of loosened or well fixed implants in patients with radiographic evidence of focal or progressive osteolysis show a high degree of vascularisation and cellular infiltrate predominated by two potential immune cells, macrophages and T lymphocytes. It is widely accepted that these cells accumulate in response to the local release of particulate wear debris generated from various types of implant material.5-7 Corrosion of metal and wear of polyethylene components or fragmentation of polymethylmethacrylate bone cement have been found to be the major cause. The mechanism responsible for the entry and accumulation of immune competent cells in the bone-implant interface is not yet clearly defined. However, the process of neovascularisation and the activation of vascular endothelium may have a major role.
Neovascularisation is essential in wound healing and tissue repair, and plays an important role in acute and chronic inflammatory conditions.8 At sites of inflammation or antigenic stimuli, vascular endothelial cells have been shown to exhibit phenotypic and morphological similarity to those of high endothelial venules in lymphoid tissues.9 Furthermore, the earlier observations of the induction of HLA-DR expression on endothelial cells,'0 production of interleukin (IL)-I, IL-6, tumour necrosis factor (TNF)ox and other cytokines, and the capacity to act as antigen-presenting cells" 12 suggest the participation of these cells in immune function. Endothelial cells are now known to play a key role in the chemotaxis, adhesion and transvascular migration of leucocytes during inflammatory reactions.'3 1 Vascular endothelial cells have been found to express at least three types of cytokine inducible adhesion molecules during activation. 1`-' Endothelial leucocyte adhesion molecule-I (ELAM-1) is now termed E-selectin; this glycoprotein belongs to the LEC-CAM (lectin, epidermal growth factor (EGF) and complement related) family of adhesion molecules.'8 19 E-selectin is important for neutrophil recruitment and may also participate in adhesion of T lymphocytes and Patients and methods Thirty patients who had osteolysis associated loosening were studied. The original joint disease was rheumatoid arthritis (RA) (n = 8) and osteoarthritis (OA) (n = 21), five of which were secondary OA (post-traumatic, osteonecrosis, or congenital dysplasia/dislocation of the hip); data were not available for one patient. Table 1 lists brief clinical details of the patients.
Specimens of the bone-implant interface on the femoral, acetabular, or tibial side were obtained during revision of total hip replacement (THR) (n= 19), or total knee replacements (TKR) (n = I1). Small pieces of each sample were immediately embedded in OCT, snap frozen in liquid nitrogen cooled isopentane and stored at -70°C.
IMMUNOHISTOCHEMISTRY
Cryostat sections 5 ,um thick were cut from at least two frozen tissue blocks from each patient and left to dry at room temperature for a minimum of two hours. The sections were then fixed in a mixture of acetone/methanol (50/50) at -20°C for 10 minutes, washed with 0-05 mol/l Tris-HCl buffered saline, pH 7-6 (TBS), and stained with the biotin streptavidin alkaline phosphatase technique. Table 2 lists the antibodies used; they include: mouse monoclonal antibodies (MAb) to the adhesion molecules E-selectin, VCAM-1,28 ICAM-1; integrins LFA-I (CD II a/CD 18), C3bi receptor (CR3, CDi lb/CD18); T cell subsets CD4/ helper, CD8/suppressor, CD45RA naive T cells and CD45RO memory T cells; also an antibody to macrophage associated antigen, CD68. A monoclonal antibody specific for prolyl 4-hydroxylase, an enzyme involved in the synthesis of collagens, was used as a marker of fibroblasts. A polyclonal rabbit anti-human Von-Willebrand factor (factor VIII) antibody was used for labelling of endothelial cells.
The tissue sections were incubated with the primary antibodies (diluted as shown in table 2) for one hour at room temperature. This was followed by one hour of incubation with biotinylated horse anti-mouse IgG. Alkaline phosphatase-streptavidin conjugate was added to all slides for one hour of incubation. Sections labelled with antibody to factor VIII related antigens were stained with binding included replacing the primary antibody with TBS or non-immune immunoglobulin from the same species as the first antibody; in addition, one section from each patient was incubated with the substrate only, to exclude the detection of endogenous alkaline phosphatase in endothelial cells.
Results
A distinct pattern of vascular growth and a prominent macrophage and lymphocytic infiltrate were evident in the bone-implant interface obtained from the 30 patients studied. In addition, a variable number of FBGCs were present throughout the sections. All patients showed one or more types of particulate implant material within the cytoplasm of the phagocytic macrophages and FBGCs, in addition to that in the extracellular matrix. As macrophages predominate in these tissues, staining for CD68 highlighted the histological pattern of the cellular infiltrate, whereas staining for factor VIII revealed the characteristics of the vascular growth. The patients were classified into three grades depending on the pattern of distribution of the cellular infiltrate. Figure 5 Expression ofE-selectin in vessels adjacent to metal-debris-containing macrophages (arrows). Horizontal bar represents 10 ,tm.
found in 21 patients. coexpression of E-selectin and VCAM-1 on endothelium in five subjects-one each in grade A and B and three in grade C. Three of these patients showed marked upregulation of the two adhesion molecules in association with metal wear debris (E-selectin 70-90% and VCAM-1 25-40%). In addition to vascular endothelium, VCAM-1 was more frequently detected in the lining cells on the implant side (n = 13) (fig 6) . The An important finding in this study was that E-selectin expression correlated significantly with the presence of metal debris which was identifiable in 11 of the 21 positive patients. Furthermore, among these patients VCAM-1 was co-expressed with E-selectin in three. E-selectin is known to mediate T cell adhesion and migration, and naive, resting, and activated memory T cells utilise this pathway. 38 The prolonged expression of E-selectin may contribute at least partially to the circulation of memory T cells sensitised to metal.
Upregulation of E-selectin and VCAM-1 on vascular endothelium has been reported in relation to hypersensitivity mediated immune reactions such as allergic and toxic dermatitis.39 40 Generation of contact hypersensitivity reactions to titanium or cobalt chrome hip prostheses in patients has been described.4l13 Of additional interest is the report by Panigutti et a144 on the presence of metal wear debris in the serum of patients with failed prostheses. This would be caused by the release of debris-containing phagocytes into the circulation. The possibility of recruitment of primed memory T cells into the inflammatory site within the joint after their contact with metal in the blood is likely. This is supported by our observation that T lymphocytes in the interface are frequently of the helper type and CD45RO positive. However, there is no direct evidence on the role of these cells in the initiation of the immune response to metal implants as they lack the expression of activation markers, including detectable IL-2 and IL-2 receptors.35 VCAM-1 plays a central role in T cell and monocyte adhesion through its interaction with the integrin VLA-4 which is expressed by these cells. 24 45 Unlike E-selectin, the VCAM-1 mediated pathway of adhesion requires activation of both the receptor and the ligand. 46 4 The lack of expression of VCAM-1 on vascular endothelium in the majority of our patients suggests a limited contribution in the recruitment of inflammatory cells. VCAM-1, however, has been demonstrated in significant concentrations on vessels in inflammatory joint conditions such as rheumatoid arthritis. 48 49 In addition to binding to VCAM-1 on endothelium, VLA-4 has an extracellular matrix ligand, CS 1 of fibronectin. This adhesion pathway was found to be responsible for the binding and retention of T cells in rheumatoid synovium." 5 As fibronectin is present in abundance in the bone-implant interface, further analysis of the expression of these important integrins on T cells and on phagocytes should help to identify the precise mechanism of accumulation of these cells on the implant surface and their role in the development of local inflammatory response. In this study, ICAM-1 expression was more prominent on the lining cells (22 patients) than on vascular endothelium (13 patients). It was also more detectable on vessels in the deeper layer and absent from all small proliferating vessels of the lining layer on the implant side. This differential expression may suggest that ICAM-1 participation in transendothelial migration of cells in these tissues is restricted, and that its induction on lining cells may serve to regulate important cell-cell interactions and not endothelium-cell adhesion. The first explanation is consistent with our finding of the presence of perivascular T cell aggregates in the deeper layers in association with ICAM-1 positive vessels; T cells in all patients showed significant expression of LFA-1, the receptor for ICAM-1.
The expression of ICAM-1 and CR3 on subsets of macrophage aggregates on the implant side may be of particular importance in maintaining a prolonged immune response at sites of particulate debris release. ICAM-1 has been shown to regulate immune functions requiring cell-cell contact55 56 and adherence of cells may regulate the process of cell activation mediated by the inflammatory cytokines, chemotactic factors and enzymes released by phagocytes. 57 However, an additional function of these receptors in homotypic adhesion is possible. The role of ICAM-1 in homotypic adhesion has been best described in haematopoietic cell lines and tumours. Analysis of myeloid and lymphoid cell lines showed strong correlation between ICAM-1 expression and the formation of spontaneous cell aggregates.58 Likewise, ICAM-1 was found to be the major determinant involved in regulating tumour behaviour. Lymphomas with weak ICAM-1 expression were described to have a diffuse pattern of spread associated with a leukaemic process, whereas those with intense ICAM-1 expression show tightly aggregated large masses.' 59 
